[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Monopolies in publishing
- To: <liblicense-l@lists.yale.edu>
- Subject: RE: Monopolies in publishing
- From: "D Anderson" <danderson@corhealth.com>
- Date: Wed, 16 Jul 2003 21:47:20 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
It's true that to the consumer, there doesn't seem much evidence of economies of scale. One factor the consumer doesn't readily have is data on changes in the number of subscribers a given journal may experience. It may be the case that economies of scale were achieved but were offset by a drop in subscribers. In that case, the price may stay the same, but at considerable effort by the publisher to reduce costs in the face of declining revenues. That's certainly been the case with some of our publications. The first thing we do if the subscriber base declines for one of our publications is to find ways to trim expenses while maintaining quality. Only after we've taken steps to reduce costs do we consider raising prices because we know that higher prices will encourage more customers to drop their subscriptions. Consumers, of course, see none of this process. They only see that prices remain the same or increase. Given the comments I've seen posted here and elsewhere, libraries have been cutting back subscriptions (indicating some level of price elasticity ). For evidence, check the postal statements periodical mailers are required to publish in issues coming out near the end of the year. They show circulation statistics and a comparison over time will yield subscription trends. The statements I track in the healthcare field overall show a circulation decline over the past two years. I know that my fellow publishers have focused substantial energy on cutting costs. So it is reasonable to assume that any economies of scale that may have been achieved were offset to some extent by a declining subscriber base. Dean H. Anderson COR Health Insight ... not just news http://www.corhealth.com -----Original Message----- [mailto:owner-liblicense-l@lists.yale.edu]On Behalf Of Hamaker, Chuck Sent: Tuesday, July 15, 2003 1:41 PM To: 'liblicense-l@lists.yale.edu'; 'espositoj@worldnet.att.net' Subject: RE: Monopolies in publishing In response to Jose Esposito: There isn't much evidence of economies of scale in Elsevier and other large journals publishers operations. Per page/per journal,per 1000 character or per 10,000 characters if you look at price to libraries, economy of scale, if it exists, doesn't show in the pricing. The market has been so inelastic I believe, that large publishers have had little incentive to look for means to internalize real savings in production costs. And anecdotally, editor's processess have been fairly well stuck in the 50's for many publishers. Even IF the publishing house has "electronic" forwarding of mss to editors and reviewers, my guestimate from talking with various publishers, is that less than 50% of editors actually use the newer and potentially more cost effective means for transmitting mss for review, processing, etc. True In house, i".e. "typesetting", layout, proofing, etc. there may be scale savings, but even that's hard to tell, and is where you would expect the most cost savings/economy of scale. But now some publisher's tell us that the "in house" what they have control over costs are not the significant piece of the puzzle. Just my opinion, backed with a fair amount of research done by many others.-Cost(i.e. subscription price) per k/character studies have been a standard for 40 years or more, and they haven't shown much if any economy of scale with commercial publishers. Chuck Hamaker
- Prev by Date: RE: Monopolies in publishing
- Next by Date: Intertrust vs. Microsoft (DRM patent disputes)
- Previous by thread: RE: Monopolies in publishing
- Next by thread: RE: Monopolies in publishing
- Index(es):